Dashboard
Manage Tickers

VRTXVERTEX PHARMACEUTICALS INC ...

Nasdaq vrtx.com


$ 393.51 $ 0.38 (0.1 %)    

Thursday, 18-Apr-2024 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 422.80 $ -2.43 (-0.57 %)
DIA $ 377.76 $ 0.39 (0.1 %)
SPY $ 499.54 $ -1.03 (-0.21 %)
TLT $ 88.82 $ -0.45 (-0.5 %)
GLD $ 220.32 $ 0.75 (0.34 %)
$ 393.48
$ 395.95
$ 0.00 x 0
$ 0.00 x 0
$ 391.14 - $ 396.06
$ 316.43 - $ 448.40
942,996
na
102.54B
$ 0.51
$ 29.55
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-15-2024 12-31-2023 10-K
2 11-07-2023 09-30-2023 10-Q
3 08-02-2023 06-30-2023 10-Q
4 05-02-2023 03-31-2023 10-Q
5 02-10-2023 12-31-2022 10-K
6 10-28-2022 09-30-2022 10-Q
7 08-05-2022 06-30-2022 10-Q
8 05-06-2022 03-31-2022 10-Q
9 02-09-2022 12-31-2021 10-K
10 11-03-2021 09-30-2021 10-Q
11 07-30-2021 06-30-2021 10-Q
12 04-30-2021 03-31-2021 10-Q
13 02-11-2021 12-31-2020 10-K
14 10-30-2020 09-30-2020 10-Q
15 07-31-2020 06-30-2020 10-Q
16 05-01-2020 03-31-2020 10-Q
17 02-13-2020 12-31-2019 10-K
18 10-31-2019 09-30-2019 10-Q
19 08-01-2019 06-30-2019 10-Q
20 05-01-2019 03-31-2019 10-Q
21 02-13-2019 12-31-2018 10-K
22 10-25-2018 09-30-2018 10-Q
23 07-26-2018 06-30-2018 10-Q
24 04-27-2018 03-31-2018 10-Q
25 02-15-2018 12-31-2017 10-K
26 10-30-2017 09-30-2017 10-Q
27 07-28-2017 06-30-2017 10-Q
28 04-28-2017 03-31-2017 10-Q
29 02-23-2017 12-31-2016 10-K
30 10-31-2016 09-30-2016 10-Q
31 08-01-2016 06-30-2016 10-Q
32 05-03-2016 03-31-2016 10-Q
33 02-16-2016 12-31-2015 10-K
34 10-30-2015 09-30-2015 10-Q
35 08-04-2015 06-30-2015 10-Q
36 05-04-2015 03-31-2015 10-Q
37 02-13-2015 12-31-2014 10-K
38 11-06-2014 09-30-2014 10-Q
39 07-31-2014 06-30-2014 10-Q
40 05-05-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

tesla-to-123-here-are-10-top-analyst-forecasts-for-thursday
Tesla To $123? Here Are 10 Top Analyst For...
04/18/2024 12:46:42

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

vertex-pharmaceuticals-announced-advancements-across-its-suzetrigine-pain-program-for-acute-and-neuropathic-pain
Vertex Pharmaceuticals Announced Advanceme...
04/18/2024 12:05:48

Rolling submission for suzetrigine moderate-to-severe acute pain NDA granted by FDA; first module submitted and on track to c...

guggenheim-maintains-buy-on-vertex-pharmaceuticals-raises-price-target-to-450
Guggenheim Maintains Buy on Vertex Pharmac...
04/18/2024 11:44:58

Guggenheim analyst Debjit Chattopadhyay maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy and raises the price targe...

if-you-invested-1000-in-this-stock-10-years-ago-you-would-have-6000-today
If You Invested $1000 In This Stock 10 Yea...
04/16/2024 16:00:35

oppenheimer-maintains-outperform-on-vertex-pharmaceuticals-maintains-500-price-target
Oppenheimer Maintains Outperform on Vertex...
04/15/2024 11:53:25

Oppenheimer analyst Hartaj Singh maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Outperform and maintains $500 price t...

the-analyst-landscape-16-takes-on-vertex-pharmaceuticals
The Analyst Landscape: 16 Takes On Vertex ...
04/12/2024 17:01:09

canaccord-genuity-maintains-sell-on-vertex-pharmaceuticals-maintains-371-price-target
Canaccord Genuity Maintains Sell on Vertex...
04/12/2024 16:01:57

Canaccord Genuity analyst Whitney Ijem maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Sell and maintains $371 price t...

vertexs-alpine-acquisition-unpacking-analyst-predictions-on-povetacicepts-potential-impact
Vertex's Alpine Acquisition: Unpacking Ana...
04/11/2024 18:47:33

Vertex Pharmaceuticals to acquire Alpine Immune Sciences for $4.9 billion, expanding into nephrology with promising APOL1-media...

stocks-bounce-back-with-tech-gold-gaining-after-modest-producer-inflation-data-whats-driving-markets-thursday
Stocks Bounce Back With Tech, Gold Gaining...
04/11/2024 18:13:17

Investors can breathe a sigh of relief on Thursday as last month’s Producer Price Index (PPI) inflation turned out slightly low...

vertex-pharmaceuticals-moves-beyond-10b-cystic-fibrosis-franchise-pays-around-5b-for-kidney-disease-player-alpine-immune
Vertex Pharmaceuticals Moves Beyond $10B C...
04/11/2024 13:01:11

Vertex Pharmaceuticals to acquire Alpine Immune Sciences for $4.9 billion in cash. Povetacicept, a potent dual antagonist of BA...

hc-wainwright--co-maintains-buy-on-vertex-pharmaceuticals-raises-price-target-to-462
HC Wainwright & Co. Maintains Buy on Verte...
04/11/2024 11:51:11

HC Wainwright & Co. analyst Andrew Fein maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy and raises the price t...

wall-street-braces-for-another-red-day-ahead-of-more-inflation-data-while-bitcoin-holds-above-70k-analyst-sees-any-pullback-as-phenomenal-buying-opportunity
Wall Street Braces For Another Red Day Ahe...
04/11/2024 11:27:42

The negative mood on Wall Street may persist as investors await the release of another inflation report, which will have signif...

evercore-isi-group-upgrades-vertex-pharmaceuticals-to-outperform-announces-438-price-target
Evercore ISI Group Upgrades Vertex Pharmac...
04/11/2024 10:50:25

Evercore ISI Group analyst Liisa Bayko upgrades Vertex Pharmaceuticals (NASDAQ:VRTX) from In-Line to Outperform and announce...

Core News & Articles
Vertex Subsidiary To Commence Cash Tender ...
04/10/2024 20:05:17

The transaction is expected to close in the second quarter of 2024. Alpine's lead molecule, povetacicept (ALPN-303), is a h...

Core News & Articles
Vertex Enters Into Agreement To Acquire Al...
04/10/2024 20:02:17

jim-cramer-was-upset-at-this-hostile-takeover-but-they-fixed-the-situation-stocks-been-a-horse
Jim Cramer Was Upset At This Hostile Takeo...
04/09/2024 13:10:29

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he prefers Abbott Laboratories (NYSE: ABT) over

reported-earlier-vertex-advances-inaxaplin-into-phase-3-portion-of-adaptive-phase-23-clinical-trial-for-the-treatment-of-apol1-mediated-kidney-disease
Reported Earlier, Vertex Advances Inaxapli...
04/01/2024 15:02:17

– 45 mg once daily oral dose selected for Phase 3 –– Results support trial expansion to lower age group and study will now incl...

vertex-announces-new-drug-submission-for-exagamglogene-autotemcel-has-been-accepted-for-priority-review-by-health-canada-for-the-treatment-of-sickle-cell-disease-and-transfusion-dependent-beta-thalassemia
Vertex Announces New Drug Submission For E...
04/01/2024 15:01:36

-Exa-cel is the first CRISPR-based gene-edited therapy to be submitted for Health Canada review-TORONTO, April 1, 2024 /CNW/ - ...

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
03/28/2024 17:35:26

if-you-invested-100-in-this-stock-20-years-ago-you-would-have-4400-today
If You Invested $100 In This Stock 20 Year...
03/25/2024 21:30:28

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

04/22/2024 Dick's Sporting Goods, Inc. (DKS)
04/22/2024 Innodata Inc. (INOD)
04/22/2024 Fox Factory Holding Corp. (FOXF)
04/23/2024 Lantronix, Inc. (LTRX)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)